Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection

Microbiology and Immunology

Volumn 40, Issue 11, 1996, Pages 827-835

  Ohshiro, Yukako ^a   Murakami, Tsutomu ^a   Matsuda, Kazuhiro ^a   Nishioka, Kiyoshi ^a   Yoshida, Keiichi ^b   Yamamoto, Naoki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

Glycosaminoglycans; Heparan sulfate; Heparitinase I; HIV 1

Indexed keywords

ENZYME; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MONOCLONAL ANTIBODY; SODIUM CHLORATE;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CELL LINE; CELL SURFACE; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MONONUCLEAR CELL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0030459394     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01148.x     Document Type: Article

References (35)

1. Baba, M., Pauwels, R., Balzarini, J., Arnout, J., and Desmyter, J. 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 85: 6132-6136.
2. Callahan, L.N., Phelan, M., Mallinson, M., and Norcross, M.A. 1991. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65: 1543-1550.
3. Callebaut, C., Krust, B., Jacotot, E., and Hovanessian, A.G. 1993. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262: 2045-2050.
4. Compton, T., Nowlin, D.M., and Cooper, N.R. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193: 834-841.
5. Dalgleish, A.C., Beverley, P.C., Clapham, P.R., Crawford, D.H., Greaves, M.F., and Weiss, R.A. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767.
6. David, G., Bai, X.M., van der Schueren, B., Cassiman, J.J., and van den Berghe, H. 1992. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119: 961-975.
7. Harada, S., Koyanagi, Y., and Yamamoto, N. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
8. Harouse, J.M., Kunsch, C., Hartle, H.T., Lauphlin, M.A., Hoxie, J.A., Wigdahl, B., et al. 1989. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63: 2527-2533.
9. Harouse, J.M., Bhat, S., Spitalnik, S.L., Laughlin, M., Stefano, K., Silberberg, D.H., et al. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253: 320-323.
10. Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N. 1989. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248: 48-52.
11. Ishihara, M. 1993. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trends Glycosci. Glycotech. 5: 343-354.
12. Ishihara, M., Shaklee, P.N., Yang, Z., Liang, W., Wei, Z., Stack, R.J., et al. 1994. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor. Glycobiology 4: 451-458.
13. Keller, K.M., Brauer, P.R., and Keller, J.M. 1989. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28: 8100-8107.
14. Kido, H., Fukutomi, A., and Katunuma, N. 1990. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HlV-1. J.Biol.Chem. 265: 21979-21985.
15. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., et al. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767-768.
16. Kolset, S.O., and Gallagher, J.T. 1990. Proteoglycans in haemopoietic cells. Byochim. Biophys. Acta 1032: 191-211.
17. Koyanagi, Y., Harada, S., Takahashi, M., Uchino, F., and Yamamoto, N. 1985. Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines. Int. J. Cancer 36: 445-451.
18. Lederman, S., Gulick, R., and Chess, L. 1989. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. J. Immunol. 143: 1149-1154.
19. Milich, L., Margolin, B., and Swanstrom, R. 1993. V3 loop of the human immunodeficiency virus type 1 env protein: interpreting sequence variability. J. Virol. 67: 5623-5634.
20. Morikawa, Y., Barsov, E., and Jones, I. 1993. Legitimate and illegitimate cleavage of human immunodeficiency virus glycoproteins by furin. J. Virol. 67: 3601-3604.
21. Okayama, M., Oguri, K., Yoshida, K., and Ohshita, T. 1991. Purification and characterization of novel heparan sulfate proteoglycans produced by murine erythroleukemia cells in the growing phase. J. Biol. Chem. 266: 3808-3819.
22. Parish, C.R., Low, L., Warren, H.S., and Cunningham, A.L. 1990. A polyanion binding site on the CD4 molecule; proximity to the HIV-gp120 binding region. J. Immunol. 145: 1188-1195.
23. Patel, M., Yanagishita, M., Roderiquez, G., Bouhabib, D.C., Oravecz, T., Hascall, V.C., et al. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 9: 167-174.
24. Rapraeger, A.C., Krufla, A., and Olwin, B.B. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1708.
25. Roderiquez, G., Oravecz, T., Yanagishita, M., Bouhabib, D.C., Mostowski, H., and Norcross, M.A. 1995. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J.Virol. 69: 2233-2239.
26. Schols, D., Pauwels, R., Desmyter, J., and De Clercq, E. 1990. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 175: 556-561.
27. Schols, D., Baba, M., Pauwels, R., and De Clercq, E. 1989. Flow cytometric method to demonstrate whether anti-HIV-1 agents inhibit virion binding to T4+ cells. J. Acquired Immune Defic. Syndr. 2: 10-15.
28. Shieh, M., Wudunn, D., Montgomery, R.I., Esko, J.D., and Spear, P.G. 1992. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116: 1273-1281.
29. Shieh, M., and Spear, P.G. 1994. Herpes virus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol. 68: 1224-1228.
30. Shioda, T., Levy, J.A., and Cheng-Mayer, C. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific region of the envelope gp120 gene. Nature 349: 167-169.
31. Shioda, T., Levy, J.A., and Cheng-Mayer, C. 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 89: 9434-9438.
32. Tateno, M., Gonzalez-Scarano, F., and Levy, J.A. 1989. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 86: 4287-4290.
33. Wudunn, D., and Spear, P.G. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63: 52-58.
34. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. 1991. Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
35. Yeaman, C., and Rapraeger, A.C. 1993. Membrane-anchored proteoglycans of mouse macrophage: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form. J. Cell. Physiol. 157: 413-425.